Latest Development Programs News

Immutep Limited reports strong progress in its Phase III lung cancer trial with over 170 patients enrolled, alongside positive FDA feedback and a robust cash position supporting ongoing development.

QPM Energy has made significant strides in advancing its 112MW Isaac Power Station, securing major financing and operational milestones that position it well for mid-2027 commissioning.

Yandal Resources has confirmed a significant new gold discovery at its Arrakis prospect, supported by strong drilling results, and secured $13.5 million in fresh capital to fast-track exploration across key projects.

Radiopharm Theranostics has secured FDA approval to initiate a Phase I trial targeting B7H3 and raised A$40 million to accelerate its radiopharmaceutical programs. The company also appointed renowned oncologist Dr Oliver Sartor to its Scientific Advisory Board.

FireFly Metals has reported a major breakthrough at its Green Bay Copper-Gold Project in Canada, revealing an extensive 800-metre-long core of exceptionally high-grade mineralisation. This discovery is set to significantly influence the upcoming Mineral Resource Estimate and economic assessments.

PYC Therapeutics has reported significant progress across its four RNA therapeutic programs targeting genetic diseases, alongside a strong cash runway supporting ongoing development.

Blackstone Minerals has secured $22.6 million to accelerate exploration at its Mankayan Copper-Gold Project in the Philippines, revealing promising high-grade surface mineralization and advancing community and regulatory approvals. The company also formed a strategic joint venture to develop its Ta Khoa Nickel Project in Vietnam, positioning itself in the growing battery metals market.

Empire Resources has completed a 42-hole air core drilling campaign at its Yuinmery Project, targeting copper-gold mineralisation, with assay results pending. Recent reverse circulation drilling has already revealed encouraging copper-gold intercepts, underpinning the company’s exploration momentum.

Diatreme Resources reports significant improvements in mineral recoveries from metallurgical testwork on its Cyclone zircon-rich heavy mineral sands project, enhancing prospects for project development and shareholder value.

Cochlear Limited reports steady FY25 financials alongside the launch of its innovative Nucleus Nexa cochlear implant system, setting the stage for projected double-digit profit growth in FY26.

Austral Resources Australia has locked in $40 million through a discounted share placement, setting the stage for its ASX reinstatement and ambitious expansion in Queensland's copper belt.

Veris Limited has reversed its FY24 loss to post a $2.0 million profit before tax in FY25, driven by digital growth and strategic acquisitions. The company’s focus on higher-margin consulting and advisory services underpins a positive outlook for FY26.